NCT07350694Recruiting
Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors
Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D-Afg]: Feasibility Trial in Rural Kabul-Afghanistan
Source: ClinicalTrials.gov · Last updated 20 Jan 2026
Brief summary (registry, in English)
This project aims to adapt, implement, and evaluate PLA based intervention in Rural Kabul, Afghanistan for TIIDM prevention and control.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- First submitted
- 16 Nov 2025
- Start date
- 24 Dec 2024
- Primary completion date
- 30 Nov 2026
- Lead sponsor
- HealthNet Transcultural Psychosocial Organization
- Diseases
- Type 2 diabetes
- NCT number
- NCT07350694
What you commit to
- Study type: Interventional
- Planned participants: 250
- From 24 Dec 2024 to the primary completion date, 30 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participants with reported health conditions that may hinder their active involvement in the study.
Age
- For Intervention phase: Individuals below the age of 20 years. For baseline and endline assessments (before and after the intervention): individuals below the age of 30 years.
Other
- Individuals unwilling to provide consent for participation.
- Individuals with non-compliance with research protocols
Who the study is looking for
- For intervention phase: Individuals aged 20 years and above. For baseline and endline assessments (before and after the intervention): Individuals aged 30 years and above.
- Participants residing in the randomized clusters of Kabul, Afghanistan Individuals willing to participate in the study and provide consent.
- All individuals with normoglycemia, intermediate hyperglycaemia, and diabetes are encouraged to participate.
- Participants who can attend the scheduled meetings and interventions as per the study protocol.
Age in the registry: 20 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| HealthNet TPO, Afghanistan Coordinator of this site? Confirm its status | Kabul | Afghanistan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.